GenBody America’s Diagnostic Kit Manufacturing Plant Opens and Begins Production in Southern California

SourceBusiness Wire
Date Published03/07/2022
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name GenBody, Inc.
Parent companyGenBody America, LLC
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):100
Year reshoring announced:2022
Year reshoring implemented or to be implemented:2022
Capital investment ($):10
Country(ies) from which reshored:Korea, Republic of
City reshored to:Jurupa Valley
State(s) reshored to:CA
If relevant, work nearshored to:-
Industry(ies):Medical Equipment & Supplies
Product(s) reshoredantigen testing kits
What domestic positive factors made reshoring more attractive?Government Incentives, Higher productivity, Proximity to customers/market
Find Reshoring Articles